Free Trial

Polarean Imaging (POLX) Competitors

GBX 1.65
-0.10 (-5.66%)
(As of 09/6/2024 11:46 AM ET)

POLX vs. NCYT, IUG, BELL, IHC, AVO, RUA, SUN, MHC, DEMG, and SN

Should you be buying Polarean Imaging stock or one of its competitors? The main competitors of Polarean Imaging include Novacyt (NCYT), Intelligent Ultrasound Group (IUG), Belluscura (BELL), Inspiration Healthcare Group (IHC), Advanced Oncotherapy (AVO), RUA Life Sciences (RUA), Surgical Innovations Group (SUN), MyHealthChecked (MHC), Deltex Medical Group (DEMG), and Smith & Nephew (SN). These companies are all part of the "medical devices" industry.

Polarean Imaging vs.

Polarean Imaging (LON:POLX) and Novacyt (LON:NCYT) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, risk, valuation, profitability, earnings, media sentiment and community ranking.

Polarean Imaging has higher earnings, but lower revenue than Novacyt. Novacyt is trading at a lower price-to-earnings ratio than Polarean Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Polarean Imaging£1.03M19.40-£11.88M-£0.04-41.28
Novacyt£11.58M5.07-£27.80M-£0.39-213.08

Polarean Imaging has a net margin of 0.00% compared to Novacyt's net margin of -244.34%. Novacyt's return on equity of -27.46% beat Polarean Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
Polarean ImagingN/A -86.11% -46.96%
Novacyt -244.34%-27.46%-13.43%

Polarean Imaging has a beta of 0.38, indicating that its stock price is 62% less volatile than the S&P 500. Comparatively, Novacyt has a beta of -1.86, indicating that its stock price is 286% less volatile than the S&P 500.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Polarean Imaging
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Novacyt
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

In the previous week, Polarean Imaging had 1 more articles in the media than Novacyt. MarketBeat recorded 2 mentions for Polarean Imaging and 1 mentions for Novacyt. Polarean Imaging's average media sentiment score of 0.00 equaled Novacyt'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Polarean Imaging
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Novacyt
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Novacyt received 13 more outperform votes than Polarean Imaging when rated by MarketBeat users. However, 67.65% of users gave Polarean Imaging an outperform vote while only 58.06% of users gave Novacyt an outperform vote.

CompanyUnderperformOutperform
Polarean ImagingOutperform Votes
23
67.65%
Underperform Votes
11
32.35%
NovacytOutperform Votes
36
58.06%
Underperform Votes
26
41.94%

12.1% of Polarean Imaging shares are held by institutional investors. Comparatively, 0.1% of Novacyt shares are held by institutional investors. 39.3% of Polarean Imaging shares are held by company insiders. Comparatively, 3.2% of Novacyt shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Polarean Imaging beats Novacyt on 10 of the 14 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding POLX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

POLX vs. The Competition

MetricPolarean ImagingMedical Devices IndustryMedical SectorLON Exchange
Market Cap£19.98M£2.07B£5.69B£1.59B
Dividend YieldN/A2.49%2.73%10.85%
P/E Ratio-41.28236.57112.071,872.22
Price / Sales19.40283.251,780.86387,638.90
Price / Cash4.9315.8138.9934.49
Price / Book0.412.805.042.56
Net Income-£11.88M£68.71M£114.87M£158.20M
7 Day Performance-4.29%-1.83%-1.52%-1.57%
1 Month Performance-2.88%-1.38%8.48%0.27%
1 Year Performance-85.64%14.38%12.50%19.28%

Polarean Imaging Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NCYT
Novacyt
0 of 5 stars
0.00 / 5 stars
GBX 83.15
+1.9%
N/A+12.6%£58.73M£11.58M-213.21120Gap Down
IUG
Intelligent Ultrasound Group
0 of 5 stars
0.00 / 5 stars
GBX 10.35
+1.0%
N/A-6.0%£33.85M£9.88M-1,034.9065Gap Down
BELL
Belluscura
0 of 5 stars
0.00 / 5 stars
GBX 12.99
+3.9%
N/A-72.7%£21.88M£1.20M-118.0924Gap Up
IHC
Inspiration Healthcare Group
0 of 5 stars
0.00 / 5 stars
GBX 22.11
-1.7%
N/A-50.8%£19.82M£37.63M-245.67210Positive News
AVO
Advanced Oncotherapy
0 of 5 stars
0.00 / 5 stars
GBX 1.75
-9.1%
N/A+0.0%£9.50MN/A-25.003,900News Coverage
Gap Down
RUA
RUA Life Sciences
0 of 5 stars
0.00 / 5 stars
GBX 10.52
-1.3%
N/A-35.3%£6.53M£2.19M-262.8848
SUN
Surgical Innovations Group
0 of 5 stars
0.00 / 5 stars
GBX 0.65
flat
N/A-60.6%£6.06M£12.01M-21.112,300Gap Up
MHC
MyHealthChecked
0 of 5 stars
0.00 / 5 stars
GBX 11.10
-1.3%
N/A+15.0%£5.77M£10.98M316.6721News Coverage
Gap Up
DEMG
Deltex Medical Group
0 of 5 stars
0.00 / 5 stars
GBX 0.12
-4.0%
N/A-35.1%£2.28M£1.78M-5.7537News Coverage
SN
Smith & Nephew
3.1011 of 5 stars
3.10 / 5 stars
GBX 1,182
+1.5%
GBX 3,956.20
+234.7%
+14.0%£10.31B£5.64B4,377.7818,452High Trading Volume

Related Companies and Tools

This page (LON:POLX) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners